awmsg logo



carglumic acid (Carbaglu®)


Reference No. 2371

Publication date:
13/12/2013


Appraisal information

carglumic acid (Carbaglu®) 200 mg dispersible tablet


Company: Orphan Europe (UK) Ltd
BNF category: Nutrition and blood
NMG meeting date: Not scheduled
AWMSG meeting date: Not scheduled
   
   
Submission Type: Nonsubmission
Status: Not endorsed
Advice No: Not available
Ratification by Welsh Government: 06/12/2013

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

AWMSG advice

In the absence of a submission from the holder of the marketing authorisation, carglumic acid (Carbaglu®) cannot be endorsed for use within NHS Wales for the treatment of hyperammonaemia due to isovaleric acidaemia; hyperammonaemia due to methymalonic acidaemia; and hyperammonaemia due to propionic acidaemia.
Statement of Advice (SOA)
Download